Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q8NA77

Entry ID Method Resolution Chain Position Source
AF-Q8NA77-F1 Predicted AlphaFoldDB

133 variants for Q8NA77

Variant ID(s) Position Change Description Diseaes Association Provenance
rs761018318
CA295189559
4 P>A No ClinGen
Ensembl
rs371327683
CA8856379
4 P>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA295189573
rs900962762
6 S>G No ClinGen
Ensembl
CA401587913
rs1245990387
6 S>R No ClinGen
gnomAD
CA401587930
rs1338083277
7 M>I No ClinGen
TOPMed
gnomAD
CA8856381
rs757728929
7 M>T No ClinGen
ExAC
TOPMed
gnomAD
CA8856383
rs143841873
8 R>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs143841873
CA8856382
8 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs868177850
CA295189588
8 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs766491977
CA295189613
9 Y>* No ClinGen
Ensembl
rs1599669527
CA401587974
10 E>D No ClinGen
Ensembl
rs1485404930
CA401587959
10 E>K No ClinGen
gnomAD
rs754747769
CA8856384
11 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1352979376
CA401588005
12 E>A No ClinGen
gnomAD
CA8856386
rs138453353
15 S>C No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA401588051
rs138453353
15 S>Y No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs146250166
CA8856389
19 A>T No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA401588143
rs1304150565
21 W>* No ClinGen
gnomAD
CA295189649
rs185078297
22 M>I No ClinGen
1000Genomes
TOPMed
gnomAD
rs1395764523
CA401588157
22 M>T No ClinGen
TOPMed
rs141219054
CA8856391
CA8856390
23 Y>* No ClinGen
ESP
ExAC
gnomAD
rs559085175
CA295189682
26 Q>R No ClinGen
Ensembl
rs1318138374
CA401588243
27 H>Q No ClinGen
gnomAD
TCGA novel 28 G>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs375937908
CA8856397
34 C>* No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs150740969
CA8856395
34 C>Y No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8856398
rs367711836
35 F>S No ClinGen
ESP
ExAC
gnomAD
CA401588345
rs1257967420
37 C>S No ClinGen
gnomAD
rs1346035716
CA401588355
38 F>L No ClinGen
gnomAD
rs768068418
CA8856399
40 A>P No ClinGen
ExAC
TOPMed
gnomAD
CA401588389
rs768068418
40 A>S No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 40 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1259349893
CA401588404
41 A>S No ClinGen
gnomAD
CA401588411
rs1185108733
41 A>V No ClinGen
Ensembl
rs559280155
CA295189784
44 D>A No ClinGen
ExAC
TOPMed
gnomAD
CA8856403
rs559280155
44 D>G No ClinGen
ExAC
TOPMed
gnomAD
rs747835900
CA8856404
47 D>E No ClinGen
ExAC
gnomAD
CA8856406
rs116114329
50 E>A No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA401588557
rs1156477833
50 E>D No ClinGen
gnomAD
CA8856407
rs777443933
52 E>D No ClinGen
ExAC
gnomAD
rs746814720
CA8856408
53 D>N No ClinGen
ExAC
TOPMed
gnomAD
rs553772038
CA8856409
54 W>* No ClinGen
1000Genomes
ExAC
gnomAD
CA401588623
rs1599669625
55 E>K No ClinGen
Ensembl
CA401588706
rs1370982897
59 W>* No ClinGen
gnomAD
CA401588709
rs1385130699
60 D>N No ClinGen
gnomAD
CA401588721
rs1331784175
61 P>R No ClinGen
TOPMed
gnomAD
TCGA novel 62 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1238536426
CA401588727
62 E>G No ClinGen
gnomAD
CA401588731
rs1266481991
63 L>M No ClinGen
gnomAD
CA401588743
rs1237394406
64 M>V No ClinGen
TOPMed
CA401588778
rs1335076626
66 H>N No ClinGen
TOPMed
CA8856412
rs769889679
66 H>Q No ClinGen
ExAC
gnomAD
rs775496340
CA8856413
67 T>A No ClinGen
ExAC
gnomAD
rs1467122406
CA401588819
69 A>T No ClinGen
gnomAD
CA8856414
rs763172270
72 E>K No ClinGen
ExAC
TOPMed
gnomAD
CA295189871
rs1024891723
73 Q>* No ClinGen
Ensembl
rs1179154699
CA401588865
75 G>A No ClinGen
gnomAD
CA401588866
rs1179154699
75 G>V No ClinGen
gnomAD
CA401588868
rs1459153804
76 S>A No ClinGen
gnomAD
CA401588870
rs1459153804
76 S>T No ClinGen
gnomAD
CA401588902
rs1302721754
78 G>V No ClinGen
TOPMed
rs1394348193
CA401588925
80 E>K No ClinGen
gnomAD
CA8856419
rs750913647
82 S>N No ClinGen
ExAC
gnomAD
CA401588982
rs1390892071
83 W>C No ClinGen
gnomAD
CA8856420
rs761225499
83 W>R No ClinGen
ExAC
TOPMed
gnomAD
CA401588988
rs1286675254
CA401588989
84 G>R No ClinGen
TOPMed
gnomAD
CA8856421
rs764863513
84 G>V No ClinGen
ExAC
gnomAD
rs1453194833
CA401589016
86 S>G No ClinGen
TOPMed
TCGA novel 86 S>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8856422
rs752196807
86 S>N No ClinGen
ExAC
CA401589033
rs1228758354
87 P>S No ClinGen
gnomAD
rs1319739886
CA401589079
90 P>H No ClinGen
gnomAD
CA8856424
rs137989980
91 V>M No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA8856425
rs777468964
92 Q>H No ClinGen
ExAC
gnomAD
CA8856426
rs147220016
93 G>W No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA295189935
rs371566517
94 G>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs371566517
CA8856428
94 G>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA295189953
rs375218867
98 W>* No ClinGen
ESP
rs1417528607
CA401589199
99 G>E No ClinGen
gnomAD
CA295189966
COSM1710911
rs140570015
99 G>R skin [Cosmic] No ClinGen
cosmic curated
ESP
rs768822950
CA8856433
101 G>R No ClinGen
ExAC
TOPMed
gnomAD
CA8856436
rs772518786
103 L>P No ClinGen
ExAC
TOPMed
gnomAD
CA401589248
rs1372613314
104 A>E No ClinGen
gnomAD
rs368255921
CA8856437
108 E>K No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA295190020
rs952000817
113 A>T No ClinGen
Ensembl
CA401589415
rs1306907568
114 G>V No ClinGen
gnomAD
rs913848768
CA295190027
115 L>P No ClinGen
TOPMed
gnomAD
CA401589455
CA401589458
rs1276102321
116 D>E No ClinGen
TOPMed
gnomAD
rs113265042
CA8856441
117 P>A No ClinGen
ExAC
gnomAD
rs113265042
CA8856440
117 P>S No ClinGen
ExAC
gnomAD
rs751255303
CA8856444
118 H>Q No ClinGen
ExAC
gnomAD
CA8856443
rs763692160
118 H>Y No ClinGen
ExAC
gnomAD
CA401589548
rs1184019063
121 P>S No ClinGen
gnomAD
CA8856445
rs199751552
125 W>* No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1381668950
CA401589643
125 W>C No ClinGen
TOPMed
rs1275880745
CA401589625
125 W>R No ClinGen
TOPMed
gnomAD
rs1403014449
CA401589652
126 P>S No ClinGen
TOPMed
rs1599669794
CA401589678
127 Q>L No ClinGen
Ensembl
CA401589688
rs1305037364
128 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
TCGA novel 128 E>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs781052597
CA8856446
128 E>V No ClinGen
ExAC
TOPMed
gnomAD
CA8856449
rs779957295
130 V>A No ClinGen
ExAC
gnomAD
rs116293085
CA8856448
130 V>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA8856447
rs116293085
130 V>M No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA401589757
rs1479032497
131 P>L No ClinGen
TOPMed
rs1449938959
CA401589788
133 G>D No ClinGen
gnomAD
rs1445863837
CA401589832
135 G>D No ClinGen
TOPMed
rs200970555
CA8856453
135 G>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA401589840
rs183087726
136 L>F No ClinGen
1000Genomes
ExAC
gnomAD
CA8856454
rs183087726
136 L>I No ClinGen
1000Genomes
ExAC
gnomAD
CA8856455
rs772130130
139 A>S No ClinGen
ExAC
TOPMed
gnomAD
rs772130130
CA401589907
139 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA8856456
rs142370714
139 A>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 140 D>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1439503805
CA401589941
141 W>R No ClinGen
TOPMed
gnomAD
CA401589983
rs1319763517
143 Q>* No ClinGen
TOPMed
CA401589996
rs1276048234
143 Q>H No ClinGen
gnomAD
rs1276472282
CA401590013
144 G>A No ClinGen
TOPMed
rs771614199
CA8856458
144 G>C No ClinGen
ExAC
gnomAD
rs555486603
RCV000957697
147 W>missing No ClinVar
dbSNP
rs759919288
CA8856461
147 W>G No ClinGen
ExAC
gnomAD
CA401590061
rs759919288
147 W>R No ClinGen
ExAC
gnomAD
CA401590102
rs1187168976
149 F>L No ClinGen
gnomAD
rs1450163917
CA401590164
152 L>I No ClinGen
gnomAD
rs1172125146
CA401590178
153 L>H No ClinGen
gnomAD
rs535694164
CA8856463
154 T>A No ClinGen
ExAC
TOPMed
gnomAD
rs1416340231
CA401590202
155 C>* No ClinGen
gnomAD
rs933781675
CA401590254
158 W>* No ClinGen
TOPMed
rs933781675
CA295190147
158 W>C No ClinGen
TOPMed
CA8856465
rs767149161
159 P>S No ClinGen
ExAC
gnomAD
rs750280258
CA8856466
161 F>S No ClinGen
ExAC
TOPMed
gnomAD
CA8856467
rs755883987
164 S>P No ClinGen
ExAC
gnomAD
CA401590351
rs1567854255
165 S>W No ClinGen
Ensembl

No associated diseases with Q8NA77

No regional properties for Q8NA77

Type Name Position InterPro Accession
No domain, repeats, and functional sites for Q8NA77

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Was initially reported to localize in the nucleus
  • However, it was later shown to localize in cytoplasm only
  • Cytoplasmic localization is distinct from the meiotic nuage, also named P granule, a germ-cell-specific organelle required to repress transposon activity during meiosis
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

1 GO annotations of molecular function

Name Definition
piRNA binding Binding to a piRNA, a Piwi-associated RNA, a 24- to 30-nucleotide RNA derived from repeat or complex DNA sequence elements and processed by a Dicer-independent mechanism.

7 GO annotations of biological process

Name Definition
cell differentiation The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
male gonad development The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
male meiotic nuclear division A cell cycle process by which the cell nucleus divides as part of a meiotic cell cycle in the male germline.
negative regulation of transposition Any process that decreases the frequency, rate or extent of transposition. Transposition results in the movement of discrete segments of DNA between nonhomologous sites.
placenta development The process whose specific outcome is the progression of the placenta over time, from its formation to the mature structure. The placenta is an organ of metabolic interchange between fetus and mother, partly of embryonic origin and partly of maternal origin.
reciprocal meiotic recombination The cell cycle process in which double strand breaks are formed and repaired through a single or double Holliday junction intermediate. This results in the equal exchange of genetic material between non-sister chromatids in a pair of homologous chromosomes. These reciprocal recombinant products ensure the proper segregation of homologous chromosomes during meiosis I and create genetic diversity.
spermatogenesis The developmental process by which male germ line stem cells self renew or give rise to successive cell types resulting in the development of a spermatozoa.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MCPPVSMRYE EEGMSYLYAS WMYQLQHGDQ LSICFTCFKA AFLDFKDLLE SEDWEEDNWD
70 80 90 100 110 120
PELMEHTEAE SEQEGSSGME LSWGQSPGQP VQGGSEAWGP GTLAAAPEGL EDAGLDPHFV
130 140 150 160
PTELWPQEAV PLGLGLEDAD WTQGLPWRFE ELLTCSHWPS FFPS